These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29211971)

  • 1. Sold as Heroin: Perceptions and Use of an Evolving Drug in Baltimore, MD.
    Mars SG; Ondocsin J; Ciccarone D
    J Psychoactive Drugs; 2018; 50(2):167-176. PubMed ID: 29211971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heroin uncertainties: Exploring users' perceptions of fentanyl-adulterated and -substituted 'heroin'.
    Ciccarone D; Ondocsin J; Mars SG
    Int J Drug Policy; 2017 Aug; 46():146-155. PubMed ID: 28735775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study.
    Carroll JJ; Marshall BDL; Rich JD; Green TC
    Int J Drug Policy; 2017 Aug; 46():136-145. PubMed ID: 28578864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urban, individuals of color are impacted by fentanyl-contaminated heroin.
    Rhodes B; Costenbader B; Wilson L; Hershow R; Carroll J; Zule W; Golin C; Brinkley-Rubinstein L
    Int J Drug Policy; 2019 Nov; 73():1-6. PubMed ID: 31330274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heroin and fentanyl overdoses in Kentucky: Epidemiology and surveillance.
    Slavova S; Costich JF; Bunn TL; Luu H; Singleton M; Hargrove SL; Triplett JS; Quesinberry D; Ralston W; Ingram V
    Int J Drug Policy; 2017 Aug; 46():120-129. PubMed ID: 28735777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence.
    Sherman SG; Morales KB; Park JN; McKenzie M; Marshall BDL; Green TC
    Int J Drug Policy; 2019 Jun; 68():46-53. PubMed ID: 30991301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptions about fentanyl-adulterated heroin and overdose risk reduction behaviors among persons seeking treatment for heroin use.
    Stein MD; Kenney SR; Anderson BJ; Bailey GL
    J Subst Abuse Treat; 2019 Sep; 104():144-147. PubMed ID: 31370978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fentanyl-contaminated drugs and non-fatal overdose among people who inject drugs in Baltimore, MD.
    Park JN; Weir BW; Allen ST; Chaulk P; Sherman SG
    Harm Reduct J; 2018 Jul; 15(1):34. PubMed ID: 29976195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fentanyl and Drug Overdose: Perceptions of Fentanyl Risk, Overdose Risk Behaviors, and Opportunities for Intervention among People who use Opioids in Baltimore, USA.
    Latkin CA; Dayton L; Davey-Rothwell MA; Tobin KE
    Subst Use Misuse; 2019; 54(6):998-1006. PubMed ID: 30767590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fentanyl, heroin, and methamphetamine-based counterfeit pills sold at tourist-oriented pharmacies in Mexico: An ethnographic and drug checking study.
    Friedman J; Godvin M; Molina C; Romero R; Borquez A; Avra T; Goodman-Meza D; Strathdee S; Bourgois P; Shover CL
    Drug Alcohol Depend; 2023 Aug; 249():110819. PubMed ID: 37348270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "It's Russian roulette": adulteration, adverse effects and drug use transitions during the 2010/2011 United Kingdom heroin shortage.
    Harris M; Forseth K; Rhodes T
    Int J Drug Policy; 2015 Jan; 26(1):51-8. PubMed ID: 25444768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvements on a chemically contiguous hapten for a vaccine to address fentanyl-contaminated heroin.
    Park H; Lee JC; Eubanks LM; Ellis B; Zhou B; Janda KD
    Bioorg Med Chem; 2021 Jul; 41():116225. PubMed ID: 34034147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supply-side response to declining heroin purity: fentanyl overdose episode in New Jersey.
    Hempstead K; Yildirim EO
    Health Econ; 2014 Jun; 23(6):688-705. PubMed ID: 23740651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polysubstance Overdose Deaths in the Fentanyl Era: A Latent Class Analysis.
    Park JN; Schneider KE; Fowler D; Sherman SG; Mojtabai R; Nestadt PS
    J Addict Med; 2022 Jan-Feb 01; 16(1):49-55. PubMed ID: 33675604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency.
    Mars SG; Ondocsin J; Ciccarone D
    Harm Reduct J; 2018 May; 15(1):26. PubMed ID: 29769132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hidden web and the fentanyl problem: Detection of ocfentanil as an adulterant in heroin.
    Quintana P; Ventura M; Grifell M; Palma A; Galindo L; Fornís I; Gil C; Carbón X; Caudevilla F; Farré M; Torrens M
    Int J Drug Policy; 2017 Feb; 40():78-83. PubMed ID: 27889114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Illicit fentanyls in the opioid street market: desired or imposed?
    Mars SG; Rosenblum D; Ciccarone D
    Addiction; 2019 May; 114(5):774-780. PubMed ID: 30512204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fentanyl epidemic hits the U.S. West Coast: Opioid-related deaths in San Francisco from 2009-2019.
    West KL; Lindquist K; Rodda LN
    Int J Drug Policy; 2021 Sep; 95():103402. PubMed ID: 34364179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The discounting of death: Probability discounting of heroin use by fatal overdose likelihood and drug purity.
    Dolan SB; Johnson MW; Dunn KE; Huhn AS
    Exp Clin Psychopharmacol; 2021 Jun; 29(3):219-228. PubMed ID: 34264734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing the growing opioid and heroin abuse epidemic: a call for medical school curricula.
    Ratycz MC; Papadimos TJ; Vanderbilt AA
    Med Educ Online; 2018 Dec; 23(1):1466574. PubMed ID: 29708863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.